Research Facility

Pittsburgh, Pennsylvania 15243

1 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Anemia, Carcinoid, Carcinoid Tumor, Chronic Kidney Disease, Chronic Renal Failure, ER+ Breast Cancer, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, HER2-negative Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. — Running, not enrolling
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis — Completed